Business · 19/07/2007
FDA Publishes Draft Guidance for Pulse Oximeter Devices
The Food and Drug Administration (FDA) has released a draft guidance outlining its recommendations for premarket notification submissions for pulse oximeter devices, which are required for devices that are substantially equivalent to a predicate device.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →